SUSOBOLIC Cooper Pharma

£69.00

SUSOBOLIC Cooper Pharma represents stanozolol research tablets designed for analytical studies investigating anabolic steroid mechanisms. This oral formulation enables laboratory evaluation of stanozolol’s molecular properties and receptor binding characteristics under controlled conditions.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
Guaranteed Safe Checkout

SUSOBOLIC Cooper Pharma
SUSOBOLIC Cooper Pharma
£69.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Research Overview: SUSOBOLIC Cooper Pharma

SUSOBOLIC Cooper Pharma is a stanozolol-based research compound formulated for comprehensive laboratory investigations. Stanozolol is a dihydrotestosterone-derived anabolic steroid characterised by its modified molecular structure featuring a pyrazole ring attachment at the A-ring position. This pharmaceutical preparation enables researchers to study stanozolol’s biochemical properties, receptor interactions, and metabolic pathways in controlled analytical environments. The compound serves as a valuable reference standard for examining anabolic steroid pharmacology and developing new analytical methodologies.

Laboratory Applications

Research institutions utilise SUSOBOLIC for diverse analytical purposes including mass spectrometry development, chromatographic method validation, and receptor binding assays. The compound proves essential for studying androgen receptor selectivity patterns and investigating tissue-specific anabolic mechanisms in cellular models. Researchers at Stroid UK Shop frequently examine stanozolol’s unique properties compared to other compounds available in our stanozolol research collection. Additionally, comparative studies often evaluate stanozolol alongside SARMs compounds to understand selective androgen modulation differences, while some investigations incorporate peptide research materials to study synergistic analytical approaches.

Product Specifications

SUSOBOLIC Cooper Pharma Technical Data
Parameter Specification
Active Compound Stanozolol
Chemical Name 17α-methyl-17β-hydroxy-5α-androst-2-eno[3,2-c]pyrazole
CAS Number 10418-03-8
Molecular Formula C₂₁H₃₂N₂O
Molecular Weight 328.49 g/mol
Form Oral tablets
Manufacturer Cooper Pharma
Storage Room temperature, dry conditions

Research Compliance Statement

SUSOBOLIC Cooper Pharma is manufactured exclusively for in-vitro laboratory research applications and analytical purposes. This product is not intended for human consumption, therapeutic use, or any form of clinical application. Researchers must maintain appropriate laboratory protocols and safety measures when handling this compound. All analytical work should comply with institutional guidelines and local regulations governing controlled substance research.

Related